Pituitary Gland Diseases And Disorders |
|
|
Clinical Trial: Evaluation of Patients with Thyroid Disorders
This study is currently recruiting patients.
Purpose
Participants in this study will be patients diagnosed with or suspected to have a thyroid function disorder. These conditions may include: hypothyroidism, hyperthyroidism, thyroid hormone resistance, Graves' Dermopathy, and thyroid-stimulating hormone (TSH) secreting pituitary adenomas.
The main purpose of this study is to further understand the natural history, clinical presentation, and genetics of thyroid function disorders. Many of the tests performed are in the context of standard medical care that is offered to all patients with thyroid function disorders. In addition, blood and tissue samples may be taken for research and genetic studies.
| Condition |
|---|
| Hyperthyroidism Hypothyroidism Pituitary Neoplasm |
MedlinePlus related topics: Brain Cancer; Brain Diseases; Cancer; Cancer Alternative Therapy; Endocrine Diseases; Pituitary Disorders; Thyroid Diseases
Study Type: Observational
Study Design: Natural History
Official Title: Evaluation of Patients with Thyroid Function Disorders
Expected Total Enrollment: 9999
Study start: January 14, 1977
Patients with thyroid function abnormalities (hyperthyroidism, hypothyroidism) are studied and treated in this protocol. A limited number of patients with a personal history of signs, symptoms or laboratory studies consistent with thyroid dysfunction or a strong family history of thyroid abnormalities are also enrolled. Patients undergo routine history and physical examination, standard endocrine blood and urine tests, a standard TRH test, thyroid nuclear medicine scans, thyroidal radioiodine (RAI) or technetium (99mTc) uptake measurements, as well as X-ray, computed tomography (CT) or magnetic resonance imaging (MRI) studies or other standard diagnostic procedures, as clinically indicated. Patients will be screened for entry into other research studies.
Eligibility
Genders Eligible for Study: Both
Criteria
Patients of any age with known or suspected thyroid abnormalities may be included in this study. These disorders can be broadly defined as hyper- or hypothyroid states and laboratory abnormalities.
Location and Contact Information
Maryland
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 9000 Rockville Pike, Bethesda, Maryland, 20892, United States; Recruiting
TTY 1-866-411-1010
More Information
Detailed Web Page
Publications
Holland FW 2nd, Brown PS Jr, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". Ann Thorac Surg. 1991 Jul;52(1):46-50.
Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med. 1993 Aug 1;119(3):236-40.
Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, Weintraub BD. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med. 1995 Oct 15;123(8):572-83.
Record last reviewed: December 17, 2004
Last Updated: December 30, 2004
Record first received: November 3, 1999
ClinicalTrials.gov Identifier: NCT00001159
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Acromegaly (National Institute of Diabetes and Digestive and Kidney Diseases)
- Cushing's Syndrome (National Institute of Diabetes and Digestive and Kidney Diseases)

Not Signed In -

